1. Home
  2. AZN vs PEP Comparison

AZN vs PEP Comparison

Compare AZN & PEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZN
  • PEP
  • Stock Information
  • Founded
  • AZN 1992
  • PEP 1898
  • Country
  • AZN United Kingdom
  • PEP United States
  • Employees
  • AZN N/A
  • PEP N/A
  • Industry
  • AZN Biotechnology: Pharmaceutical Preparations
  • PEP Beverages (Production/Distribution)
  • Sector
  • AZN Health Care
  • PEP Consumer Staples
  • Exchange
  • AZN Nasdaq
  • PEP Nasdaq
  • Market Cap
  • AZN 205.5B
  • PEP 204.8B
  • IPO Year
  • AZN 1993
  • PEP N/A
  • Fundamental
  • Price
  • AZN $67.59
  • PEP $142.84
  • Analyst Decision
  • AZN Strong Buy
  • PEP Buy
  • Analyst Count
  • AZN 7
  • PEP 15
  • Target Price
  • AZN $89.75
  • PEP $168.00
  • AVG Volume (30 Days)
  • AZN 6.8M
  • PEP 8.4M
  • Earning Date
  • AZN 04-29-2025
  • PEP 04-24-2025
  • Dividend Yield
  • AZN 2.28%
  • PEP 3.79%
  • EPS Growth
  • AZN 18.11
  • PEP 5.95
  • EPS
  • AZN 4.50
  • PEP 6.95
  • Revenue
  • AZN $54,073,000,000.00
  • PEP $91,854,000,000.00
  • Revenue This Year
  • AZN $8.64
  • PEP $1.17
  • Revenue Next Year
  • AZN $6.11
  • PEP $3.64
  • P/E Ratio
  • AZN $29.58
  • PEP $20.55
  • Revenue Growth
  • AZN 18.04
  • PEP 0.42
  • 52 Week Low
  • AZN $61.24
  • PEP $138.33
  • 52 Week High
  • AZN $87.68
  • PEP $183.41
  • Technical
  • Relative Strength Index (RSI)
  • AZN 40.79
  • PEP 43.72
  • Support Level
  • AZN $66.81
  • PEP $139.77
  • Resistance Level
  • AZN $68.40
  • PEP $147.18
  • Average True Range (ATR)
  • AZN 2.22
  • PEP 4.35
  • MACD
  • AZN -0.19
  • PEP -0.42
  • Stochastic Oscillator
  • AZN 43.91
  • PEP 27.19

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

About PEP PepsiCo Inc.

PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US and overseas. International markets make up 40% of total sales and one third of operating profits.

Share on Social Networks: